Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abera Bioscience | ABERA | Apr 30, 2024 | 4.71 | -1.26 |
Abliva | ABLI | Apr 30, 2024 | 0.17 | +1.18 |
Active Biotech | ACTI | Apr 30, 2024 | 0.56 | +1.82 |
AcuCort | ACUC | Apr 30, 2024 | 0.52 | -3.70 |
Aegirbio | AEGIR | Apr 30, 2024 | 0.49 | -1.01 |
Alligator Bioscience | ATORX | Apr 30, 2024 | 0.90 | -2.70 |
AlzeCure Pharma | ALZCUR | Apr 30, 2024 | 1.89 | -1.56 |
Alzinova | ALZ | Apr 30, 2024 | 1.12 | -3.78 |
Amniotics | AMNI | Apr 30, 2024 | 0.00 | +2.63 |
Annexin Pharmaceuticals | ANNX | Apr 30, 2024 | 0.30 | +5.26 |
Aptahem | APTA | Apr 30, 2024 | 0.03 | +0.66 |
Arcede Pharma AB | ARCEDE | Apr 30, 2024 | 0.10 | +1.04 |
AroCell | AROC | Apr 30, 2024 | 0.40 | +6.17 |
Asarina Pharma | ASAP | Apr 30, 2024 | 0.97 | -1.22 |
Ascelia Pharma | ACE | Apr 30, 2024 | 10.58 | -0.56 |
AstraZeneca | AZN | Apr 30, 2024 | 1 671.50 | +0.97 |
Attana | ATANA | Apr 30, 2024 | 0.08 | +12.50 |
Bio-Works Technologies | BIOWKS | Apr 30, 2024 | 2.94 | 0.00 |
BioArctic B | BIOAB | Apr 30, 2024 | 195.00 | -2.01 |
BioGaia B | BIOGB | Apr 30, 2024 | 117.90 | +1.20 |
BioInvent International | BINV | Apr 30, 2024 | 26.00 | +2.77 |
Biosergen | BIOSGN | Apr 30, 2024 | 0.33 | 0.00 |
Biovica International B | BIOVICB | Apr 30, 2024 | 1.59 | -0.25 |
Calliditas Therapeutics | CALTX | Apr 30, 2024 | 110.00 | +2.90 |
Camurus | CAMX | Apr 30, 2024 | 498.20 | +0.36 |
Cantargia | CANTA | Apr 30, 2024 | 3.34 | -2.74 |
Cereno Scientific B | CRNOB | Apr 30, 2024 | 3.85 | -2.23 |
Chordate Medical Holding | CMH | Apr 30, 2024 | 0.06 | +6.32 |
Chosa Oncology AB | CHOSA | Apr 30, 2024 | 1.00 | -0.20 |
Cline Scientific B | CLINEB | Apr 30, 2024 | 0.14 | -14.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.